RACHEL BARNET: Open Payments
NPI 1699359950 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 34 payments from 11 companies in 2025. Trend: 2023 $1,967 · 2024 $243 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $229 |
| QOL Medical, LLC | 5 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| Madrigal Pharmaceuticals | 1 | $44 |
| Ardelyx, Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
Products named: RINVOQ, Sucraid, EOHILIA, REZDIFFRA, IBSRELA, SKYRIZI, XIFAXAN, DUPIXENT.
Industry payments across PA — which companies pay providers there.
